跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 150,801 条关于
“bipolar I or II disorder”
全部
150,801
临床试验
119,665
药物
1,925
机构
260
资讯
28,951
22天前
Teva Bids to Acquire BioXcel's Dexmedetomidine Sublingual Film for At-Home Agitation Treatment
去年
Autobahn Therapeutics' ABX-002 Receives FDA Clearance for Bipolar Depression Trial
去年
BioXcel Therapeutics Advances Phase 3 Trials of BXCL501 for Agitation
8个月前
BioXcel Therapeutics to Submit sNDA for At-Home Use of IGALMI in Agitation Treatment
去年
Intra-Cellular's Caplyta Shows Strong Efficacy in Schizophrenia Relapse Prevention
去年
Lumateperone Shows Promise in Preventing Schizophrenia Relapse
去年
Intra-Cellular Therapies Seeks FDA Approval for Caplyta in Major Depressive Disorder
3个月前
Autobahn Therapeutics Receives FDA Fast Track Designation for Elunetirom in Bipolar Depression
去年
Intra-Cellular Therapies Seeks FDA Approval for Caplyta as Adjunctive MDD Treatment
去年
Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6 Billion, Bolstering Neuroscience Portfolio
第 1 页,共 2896 页
上一页
下一页